← Open Payments lookup

ROBIN MILLER: Open Payments

NPI 1316906159 · MOORESTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$620 in 17 payments from 8 companies in 2025. Trend: 2023 $1,582 · 2024 $304 · 2025 $620

Food & beverage: $620
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$152
ABBVIE INC.4$150
Celltrion USA Inc.1$123
Ardelyx, Inc.4$86
Janssen Biotech, Inc.1$35
Regeneron Healthcare Solutions, Inc.2$30
Ferring Pharmaceuticals Inc.1$26
Madrigal Pharmaceuticals1$18

Products named: XIFAXAN, ZYMFENTRA, IBSRELA, TREMFYA, DUPIXENT, REBYOTA, LINZESS, REZDIFFRA.

Industry payments across NJ — which companies pay providers there.